CHRONIC PLAQUE PSORIASIS

This study followed over 1,300 adults with moderate to severe plaque psoriasis for up to 3 years to see how safe and effective the medication bimekizumab is over the long term. Participants received regular injections of the drug and were monitored for side effects and skin impro…

This study tested whether a new injectable drug called bimekizumab works better than an existing drug called secukinumab for adults with moderate-to-severe plaque psoriasis. 743 participants received one of the two drugs for 48 weeks, with researchers measuring how much their ski…

This study tested an investigational drug called bimekizumab in adults with moderate to severe plaque psoriasis. It was a large, late-stage trial comparing the drug to a placebo to see how well it cleared skin and reduced symptoms like itch and pain. The main goal was to see if p…

This study tested a new medication called bimekizumab against an existing treatment, adalimumab, for adults with moderate to severe plaque psoriasis. It involved 478 participants and aimed to see which drug was better at clearing skin and improving symptoms. The study also monito…

This study tested an investigational drug called bimekizumab in adults with moderate to severe plaque psoriasis. The main goals were to see how well it cleared skin symptoms, how the drug behaved in the body, and if it was safe. Forty-nine participants received the drug and were …

This study followed over 2,700 adults with moderate-to-severe plaque psoriasis to see how well the drug risankizumab worked compared to other commonly used biologic treatments. Researchers tracked how many patients achieved clear or nearly clear skin, how long treatments worked b…

This study tested an investigational drug called bimekizumab for adults with moderate to severe plaque psoriasis. It compared bimekizumab against a placebo and an existing treatment to see how well it cleared skin plaques and reduced symptoms like itch and pain. The main goal was…

This study tested whether an injectable drug called bimekizumab is better than a placebo at clearing skin in adults with moderate to severe plaque psoriasis. It involved 133 Chinese participants who received injections for 16 weeks. Researchers measured how much the psoriasis imp…